EU Regulators Publish Roadmap to Harness AI in Medicines Through 2028
-
EMA and Heads of Medicines Agencies published an AI workplan through 2028 to maximize benefits and manage risks of using AI in medicines regulation.
-
The workplan will help embrace opportunities of AI to improve productivity, process automation, data insights, and decision-making.
-
The workplan focuses on guidance, policy and product support; AI tools and technology; collaboration and training; and experimentation.
-
Actions include developing guidance on using AI, implementing the EU AI Act, identifying frameworks to use AI tools, building network capacity, and accelerating learning through experimentation.
-
The plan will be continuously updated as the AI field evolves rapidly.